SCHEMBL3086530

SCHEMBL3086530

Cc1nc(-c2ccc(OCCCCl)cc2)sc1CC(=O)N1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.46
KMT2A Q03164 3/20 0.46
RAB9A P51151 3/20 0.46
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 2/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PPARD Q03181 4/20 0.46
PPARG P37231 2/20 0.46
PPARA Q07869 2/20 0.46
HRH3 Q9Y5N1 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
AGER Q15109 3/20 0.43
FFAR1 O14842 5/20 0.43
NPC1 O15118 2/20 0.42
TP53 P04637 2/20 0.42
MAPT P10636 1/20 0.42
KDM4E B2RXH2 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3078206 0.90 AGER (0.52) RAB9AHRH3SMN1; SMN2AGERNPC1
SCHEMBL3070582 0.82 PPARD (0.60) KMT2AMEN1PPARDPPARGPPARA
SCHEMBL13139700 0.80 TRPM8 (0.53) PPARDPPARGPPARAFFAR1TP53
SCHEMBL3082591 0.78 PPARD (0.45) PPARDPPARGPPARAFFAR1TP53
SCHEMBL3078782 0.76 ACACB (0.45) PPARDPPARGPPARAHRH3AGER
SCHEMBL3074369 0.73 HRH3 (0.71) HPGDALDH1A1PPARDPPARAHRH3
SCHEMBL3078800 0.73 AGER (0.61) HRH3AGER
SCHEMBL3071111 0.73 TARBP2 (0.70) KMT2ARAB9AALDH1A1MEN1PPARD
SCHEMBL3080685 0.73 HRH3 (0.56) HPGDKMT2ARAB9AALDH1A1MEN1
SCHEMBL3078871 0.73 HRH3 (0.56) HPGDKMT2ARAB9AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275046-A1 Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2008-11-06 US claimed
US-7790720-B2 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses UCB PHARMA, S.A. (BE) 2010-09-07 US disclosed
US-7790720-B2 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses UCB PHARMA, S.A. (BE) 2010-09-07 US disclosed
US-7790720-B2 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses UCB PHARMA, S.A. (BE) 2010-09-07 US disclosed
US-20080275046-A1 Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2008-11-06 US disclosed
US-20080275046-A1 Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2008-11-06 US disclosed
US-20080275046-A1 Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275046-A1 Compounds Comprising an Oxazole or Thiazole Moiety, Processes for Making Them, and Their Uses OXER1, OXTR, OGFR HPGD 2325/4885KMT2A 2724/4885RAB9A 4232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.